BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30318399)

  • 1. Development of a risk prediction model for hospital-onset Clostridium difficile infection in patients receiving systemic antibiotics.
    Tilton CS; Johnson SW
    Am J Infect Control; 2019 Mar; 47(3):280-284. PubMed ID: 30318399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a risk assessment model to predict infection with healthcare facility-onset Clostridioides difficile.
    Tilton CS; Sexton ME; Johnson SW; Gu C; Chen Z; Robichaux C; Metzger NL
    Am J Health Syst Pharm; 2021 Sep; 78(18):1681-1690. PubMed ID: 33954428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics.
    van Werkhoven CH; van der Tempel J; Jajou R; Thijsen SF; Diepersloot RJ; Bonten MJ; Postma DF; Oosterheert JJ
    Clin Microbiol Infect; 2015 Aug; 21(8):786.e1-8. PubMed ID: 25889357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a clinical prediction scale for hospital-onset Clostridium difficile infection.
    Chandra S; Thapa R; Marur S; Jani N
    J Clin Gastroenterol; 2014; 48(5):419-22. PubMed ID: 24172178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a Clostridium difficile infection risk prediction model.
    Dubberke ER; Yan Y; Reske KA; Butler AM; Doherty J; Pham V; Fraser VJ
    Infect Control Hosp Epidemiol; 2011 Apr; 32(4):360-6. PubMed ID: 21460487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
    Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
    Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
    J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital-wide cohort.
    Carvour ML; Wilder SL; Ryan KL; Walraven C; Qeadan F; Brett M; Page K
    Am J Infect Control; 2019 Jan; 47(1):2-8. PubMed ID: 30205907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
    Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA
    PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China.
    Li C; Duan J; Liu S; Meng X; Fu C; Zeng C; Wu A
    Infection; 2017 Oct; 45(5):621-628. PubMed ID: 28497295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
    Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
    J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity.
    Forster AJ; Daneman N; van Walraven C
    J Hosp Infect; 2017 Apr; 95(4):400-409. PubMed ID: 27825674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure.
    Johnson SW; Brown SV; Priest DH
    Clin Infect Dis; 2020 Aug; 71(5):1133-1139. PubMed ID: 31560051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.
    van Kleef E; Deeny SR; Jit M; Cookson B; Goldenberg SD; Edmunds WJ; Robotham JV
    Vaccine; 2016 Nov; 34(46):5562-5570. PubMed ID: 27727031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship Efforts.
    Kuntz JL; Smith DH; Petrik AF; Yang X; Thorp ML; Barton T; Barton K; Labreche M; Spindel SJ; Johnson ES
    Perm J; 2016; 20(1):20-5. PubMed ID: 26845084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a Clinical Prediction Rule for First Hospital-Onset Clostridium difficile Infections: A Retrospective Observational Study.
    Press A; Ku BS; McCullagh L; Rosen L; Richardson S; McGinn T
    Infect Control Hosp Epidemiol; 2016 Aug; 37(8):896-900. PubMed ID: 27123975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tipping point: patients predisposed to Clostridium difficile infection and a hospital antimicrobial stewardship programme.
    Stites SD; Cooblall CA; Aronovitz J; Singletary SB; Micklow K; Sjeime M
    J Hosp Infect; 2016 Nov; 94(3):242-248. PubMed ID: 27742079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.